Novogene America

Novogene USA is a multi-omics research services provider offering end-to-end support from biological samples through sequencing, data analysis, and research insights. Its services cover genomics, transcriptomics, single-cell and spatial omics, epigenomics, proteomics, and metabolomics. Options include whole-genome and exome sequencing, RNA sequencing, metagenomics, methylation analysis, chromatin assays, quantitative and PTM proteomics, and untargeted metabolomics. The company also offers sequencing-only services on Illumina and Ultima platforms.

Novogene reports serving more than 8,000 organizations, processing over three million samples annually, and contributing to research associated with more than 40,000 scientific publications. Its technology platforms include Illumina, Ultima, and Thermo Fisher’s Orbitrap Astral system, which supports its quantitative proteomics services. Falcon, its automated delivery platform, helps standardize workflows and manage projects, while the NovoMagic bioinformatics tool and expert team provide standardized or customized data analysis. Novogene’s services support research areas including cancer, immuno-oncology, agriculture, microbiomes, drug development, and rare and complex diseases.